Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

3.2K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.2K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

2.0K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

7.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
7.8K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

230
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
230
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

745
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
745

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Getting fairer over time? Assessing changes in health technology funding processes using the accountability for reasonableness (A4R) framework.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same author

Inherited human CARD9 deficiency impairs lymphoid cell, but not fibroblast, IL-17-mediated immunity.

JCI insight·2026
Same author

Social value of a childhood QALY - Revealed preferences from pharmaceutical funding decisions in Australia 2005-2023.

Social science & medicine (1982)·2026
Same author

Strategic Delay and Bargaining Over Public Insurance Coverage for Drugs in Australia.

Health economics·2026
Same author

The Association Between Health-Related Quality of Life Scores and Clinical Outcomes for People Living With Lung Cancer: An Australian Registry Cohort Study Using Patient-Reported Outcomes to Drive Value-Based Healthcare.

Thoracic cancer·2026
Same author

Pemphigoid Gestationis Refractive to Dual Systemic Therapy Treated With Dupilumab.

The Australasian journal of dermatology·2026

Related Experiment Video

Updated: Oct 11, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

5.2K

Epigenetic Modifications and Therapy in Uveitis.

Yanli Zou1,2, Jing Jing Li2, Wei Xue2

  • 1Department of Ophthalmology, Affiliated Foshan Hospital, Southern Medical University, Foshan, China.

Frontiers in Cell and Developmental Biology
|December 6, 2021
PubMed
Summary
This summary is machine-generated.

Epigenetic factors are crucial in understanding uveitis (intraocular inflammation). Research highlights epigenetic mechanisms and therapies for treating this sight-threatening condition.

Keywords:
DNA methylationepigenetic regulationepigenetic therapymicroRNAsuveitis

More Related Videos

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

2.9K
Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

2.2K

Related Experiment Videos

Last Updated: Oct 11, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

5.2K
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

2.9K
Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

2.2K

Area of Science:

  • Ophthalmology
  • Immunology
  • Genetics

Background:

  • Uveitis is a serious intraocular inflammation with unclear pathogenesis.
  • Genetic variations (identified via GWASs) are linked to uveitis types like VKH and BD.
  • Epigenetic regulation significantly influences uveitis immunoregulation.

Purpose of the Study:

  • To review recent advances in identifying epigenetic programs in uveitis.
  • To explore the role of epigenetics in intraocular immune responses and inflammation.
  • To highlight the potential of epigenetic therapies for uveitis.

Main Methods:

  • Review of recent scientific literature.
  • Analysis of genome-wide association studies (GWASs).
  • Examination of epigenetic mechanisms in uveitis pathology.

Main Results:

  • Epigenetic regulation plays a key role in uveitis.
  • Epigenetic therapies show promise for intraocular inflammation.
  • Understanding epigenetic mechanisms is vital for uveitis treatment.

Conclusions:

  • Epigenetic insights are advancing uveitis research.
  • Epigenetic therapies offer hope for managing sight-threatening uveitis.
  • Further research into epigenetic mechanisms can lead to novel treatments.